On ECHEMI
Home > Drugs > Acrivastine Registered Holders
Acrivastine structure

Acrivastine structure

Acrivastine

Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.

Find 4 Related Holders

BIOPHORE INDIA PHARMACEUTICALS PVT LTD
United States United States

API Registration Country

API Active
STERLING PHARMA SOLUTIONS LTD
France France

API Registration Country

API Active
  • Founded in:

    2006-04-01 00:00:00
  • Country:

    France France
  • Address:

    STERLING PLACE DUDLEY NE23 7QG NORTHUMBERLAND ROYAUME-UNI
Chongqing Shengkai Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2009-08-28
  • Country:

    China China
  • Address:

    No. 6, Huanan 1st Road, Yanjia Street, Changshou District, Chongqing
  • Tax NO.:

    91500117693916504B
  • Registered Funds:

    100 million yuan
  • Website:

  • Email:

CHONGQING HUAPONT PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Acrivastine
View 38 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.